Progress in eliminating onchocerciasis in the WHO Region of the Americas: disruption of ivermectin mass drug administration in the Yanomami focus area due to
Déclaration du Comité d’Experts de Mectizan (CEM) sur l’utilisation du Mectizan® : Le Comité rappelle à nos pays partenaires que le Mectizan® est exclusivement
A Mectizan Expert Committee (MEC) Statement on the use of Mectizan® during the COVID-19 pandemic: The MEC reminds country partners that Mectizan is donated only
The World Health Organization (WHO) announced in this week’s WHO Weekly Epidemiological Record that Malawi has been validated to have eliminated lymphatic filariasis as a public health problem.
This is footage[1] of microfilariae was captured in a 59-year-old man’s anterior chamber of the eye. The man lives in an onchocerciasis-endemic area in
A recent study informed that ivermectin was successfully used in vitro for the treatment of SARS-CoV-2 in experimentally infected cells and two preprint publications
On June 14, 2018, the US FDA approved moxidectin as a treatment for onchocerciasis (river blindness). We applaud Medicines Development for Global Health (MDGH)
The Carter Center and partners are working with Nigeria’s Ministry of Health to eliminate river blindness in nine of the country’s states, including Plateau,
